Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018


Dublin, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/55xd3g/global_single) has announced the addition of the "Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" report to their offering.

Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study.

It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight.

The analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018.


Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

18. Key Vendor Analysis

19. Other Reports in this Series


Companies Mentioned:

  • Affymetrix Inc.
  • Illumina Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Douglas Scientific Llc.
  • Fluidigm Corp.
  • Luminex Corp.
  • PREMIER Biosoft Intl.
  • Promega Corp
  • Qiagen N. V.
  • Sequenom Inc.
  • WaferGen Biosystems Inc.


For more information visit http://www.researchandmarkets.com/research/55xd3g/global_single



            

Contact Data